| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.67e-10 | 11 | 172 | 6 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.82e-07 | 32 | 172 | 6 | GO:0099186 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 DDX49 ABCA12 ACTB RNF213 DHX33 KATNAL1 MORC2 DDX3X HELB ABCB10 HFM1 ABCC12 DDX53 DNAH8 KIFC1 RAD17 | 2.84e-07 | 441 | 172 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | GRIA2 GRIA3 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 KCNA10 KCNN2 TMEM63A | 3.79e-07 | 140 | 172 | 10 | GO:0099094 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 KCNA10 KCNN2 TMEM63A | 9.42e-07 | 193 | 172 | 11 | GO:0015276 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 KCNA10 KCNN2 TMEM63A | 1.15e-06 | 197 | 172 | 11 | GO:0022834 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.52e-06 | 42 | 172 | 6 | GO:0098918 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 DDX49 MYO1D ABCA12 ACTB RNF213 DHX33 KATNAL1 MORC2 DDX3X HELB ABCB10 HFM1 ABCC12 DDX53 MYO15A DNAH8 KIFC1 RAD17 | 1.54e-06 | 614 | 172 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 2.50e-06 | 4 | 172 | 3 | GO:0004971 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1F SLC9A9 CNNM2 TRPC5 GRIA2 GRIA3 GRIN2A RYR1 RYR2 ITPR2 SLC6A1 SLC11A1 SLC12A4 KCNA10 SCN2A KCNN2 | 2.83e-06 | 465 | 172 | 16 | GO:0046873 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 6.34e-06 | 31 | 172 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1F GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 KCNA10 SCN2A KCNN2 TMEM63A | 6.81e-06 | 334 | 172 | 13 | GO:0022836 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1F SLC9A9 CNNM2 TRPC5 GRIA2 GRIA3 GRIA4 GRIN2A RYR1 RYR2 ITPR2 SLC6A1 SLC11A1 SLC12A4 KCNA10 SCN2A KCNN2 TMEM63A | 8.30e-06 | 627 | 172 | 18 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1F TRPC5 GRIA2 GRIA3 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 KCNA10 SCN2A KCNN2 TMEM63A | 9.06e-06 | 343 | 172 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 1.16e-05 | 17 | 172 | 4 | GO:0004970 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1F TRPC5 GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 SLC12A4 KCNA10 SCN2A KCNN2 GJA10 TMEM63A | 1.30e-05 | 525 | 172 | 16 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1F TRPC5 GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 SLC12A4 KCNA10 SCN2A KCNN2 GJA10 TMEM63A | 1.33e-05 | 526 | 172 | 16 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1F SLC9A9 CNNM2 TRPC5 GRIA2 GRIA3 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 SLC6A1 SLC11A1 SLC12A4 KCNA10 SCN2A KCNN2 TMEM63A | 1.79e-05 | 664 | 172 | 18 | GO:0008324 |
| GeneOntologyMolecularFunction | calmodulin binding | MYO1D CAMSAP3 OBSCN RYR1 RYR2 ADD3 IQGAP1 SCN2A KCNN2 MYO15A | 3.18e-05 | 230 | 172 | 10 | GO:0005516 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH3 DDX49 ABCA12 ACTB ATL3 RNF213 DHX33 KATNAL1 MORC2 DDX3X HELB ABCB10 RASD1 HFM1 ABCC12 DDX53 DNAH8 KIFC1 RAD17 | 4.12e-05 | 775 | 172 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1F TRPC5 GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 KCNA10 SCN2A KCNN2 TMEM63A | 4.58e-05 | 459 | 172 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 4.94e-05 | 24 | 172 | 4 | GO:0099507 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1F SLC9A9 CNNM2 TRPC5 GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 SLC6A1 SLC11A1 SLC12A4 KCNA10 SCN2A KCNN2 TMEM63A | 5.61e-05 | 793 | 172 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | protein kinase binding | RASGRF1 POTEF RAB11FIP2 ACTB ACTG1 GRIA2 POTEKP GRIN2A RYR2 ADD3 IQGAP1 POTEE TGIF1 MAPK14 SLC12A4 CD44 APPL1 ZFYVE26 LRBA POTEI | 6.58e-05 | 873 | 172 | 20 | GO:0019901 |
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 7.38e-05 | 2 | 172 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 7.38e-05 | 2 | 172 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 7.38e-05 | 2 | 172 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 7.99e-05 | 27 | 172 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | kinase binding | RASGRF1 POTEF RAB11FIP2 ACTB ACTG1 GRIA2 POTEKP GRIN2A RYR2 ADD3 IQGAP1 POTEE TGIF1 MAPK14 SLC12A4 CD44 APPL1 ZFYVE26 LRBA BCAR3 POTEI | 9.41e-05 | 969 | 172 | 21 | GO:0019900 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1F SLC9A9 CNNM2 TRPC5 GRIA2 GRIA3 GRIA4 GRIN2A RYR1 RYR2 ITPR2 SLC6A1 SLC11A1 SLC12A4 KCNA10 SCN2A KCNN2 TMEM63A | 9.94e-05 | 758 | 172 | 18 | GO:0015318 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH3 DDX49 ABCA12 ACTB ATL3 RNF213 DHX33 KATNAL1 MORC2 DDX3X HELB ABCB10 RASD1 HFM1 ABCC12 DDX53 DNAH8 KIFC1 RAD17 | 1.18e-04 | 839 | 172 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH3 DDX49 ABCA12 ACTB ATL3 RNF213 DHX33 KATNAL1 MORC2 DDX3X HELB ABCB10 RASD1 HFM1 ABCC12 DDX53 DNAH8 KIFC1 RAD17 | 1.19e-04 | 840 | 172 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH3 DDX49 ABCA12 ACTB ATL3 RNF213 DHX33 KATNAL1 MORC2 DDX3X HELB ABCB10 RASD1 HFM1 ABCC12 DDX53 DNAH8 KIFC1 RAD17 | 1.19e-04 | 840 | 172 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | calcium channel activity | 1.29e-04 | 129 | 172 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.30e-04 | 57 | 172 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.35e-04 | 130 | 172 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.67e-04 | 60 | 172 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.79e-04 | 33 | 172 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1F SLC9A9 CNNM2 ABCA12 TRPC5 GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 SLC6A1 SLC11A1 ABCB10 SLC12A4 KCNA10 SCN2A KCNN2 ABCC12 GJA10 TMEM63A | 2.07e-04 | 1180 | 172 | 23 | GO:0022857 |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.43e-04 | 65 | 172 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.43e-04 | 65 | 172 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.40e-04 | 151 | 172 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | zinc ion sequestering activity | 4.38e-04 | 4 | 172 | 2 | GO:0140486 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 4.38e-04 | 4 | 172 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 4.66e-04 | 18 | 172 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 4.75e-04 | 75 | 172 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 5.36e-04 | 77 | 172 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1F SLC9A9 CNNM2 ABCA12 TRPC5 GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 ITPR2 SLC6A1 SLC11A1 ABCB10 SLC12A4 KCNA10 SCN2A KCNN2 ABCC12 GJA10 TMEM63A | 7.15e-04 | 1289 | 172 | 23 | GO:0005215 |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 7.25e-04 | 5 | 172 | 2 | GO:0106294 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.08e-03 | 6 | 172 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 1.51e-03 | 7 | 172 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.74e-03 | 100 | 172 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | metal ion sequestering activity | 2.00e-03 | 8 | 172 | 2 | GO:0140487 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 2.00e-03 | 8 | 172 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.16e-03 | 105 | 172 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | helicase activity | 2.50e-03 | 158 | 172 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SPATA6L MYO1D TRPC5 ACTB CAMSAP3 OBSCN GRIA2 KATNAL1 NEB FMNL2 DDX3X ADD3 IQGAP1 SETD2 KCNN2 APPL1 MYO15A AGBL1 KIFC1 | 3.01e-03 | 1099 | 172 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | CYSLTR2 OR5M1 OR4K13 OR4Q2 GPR33 OR1F2P GRIA2 GRIA3 GRIA4 GPR63 GRIN2A OR14C36 CHRNA1 S1PR3 OR2M4 TAS2R10 OR5H6 CD44 OR5H2 OR8B12 OR4K3 TMEM63A | 3.01e-03 | 1353 | 172 | 22 | GO:0004888 |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 3.09e-03 | 34 | 172 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.58e-03 | 118 | 172 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.59e-03 | 227 | 172 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5M1 OR4K13 OR4Q2 OR1F2P OR14C36 OR2M4 OR5H6 OR5H2 OR8B12 OR4K3 | 4.27e-03 | 431 | 172 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 4.60e-03 | 12 | 172 | 2 | GO:0016174 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 4.60e-03 | 12 | 172 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 4.62e-03 | 78 | 172 | 4 | GO:0003724 | |
| GeneOntologyMolecularFunction | odorant binding | 4.89e-03 | 127 | 172 | 5 | GO:0005549 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 5.00e-03 | 182 | 172 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 5.06e-03 | 80 | 172 | 4 | GO:0008186 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 5.27e-03 | 184 | 172 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 5.41e-03 | 13 | 172 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | calcium ion binding | PADI4 PCDHGB1 DUOX2 ITIH4 RYR1 RYR2 IQGAP1 ITPR2 S100A7 MYOF S100A7A DUOX1 FBN2 JAG1 | 5.46e-03 | 749 | 172 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 6.02e-03 | 43 | 172 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 6.27e-03 | 14 | 172 | 2 | GO:0070679 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.66e-07 | 31 | 168 | 6 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 3.56e-07 | 35 | 168 | 6 | GO:0099188 | |
| GeneOntologyBiologicalProcess | synapse organization | DOCK1 POTEF ACTB ACTG1 LAMB2 POTEKP GRIN2A CHRNA1 SLC6A1 POTEE KY LRRN3 MAPK14 APPL1 TANC1 GJA10 POTEI | 4.63e-05 | 685 | 168 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 6.11e-05 | 10 | 168 | 3 | GO:0072310 | |
| GeneOntologyBiologicalProcess | podocyte development | 6.11e-05 | 10 | 168 | 3 | GO:0072015 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 6.44e-05 | 27 | 168 | 4 | GO:0035235 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 5.89e-09 | 32 | 170 | 7 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 5.89e-09 | 32 | 170 | 7 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 7.27e-08 | 45 | 170 | 7 | GO:1902562 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.17e-05 | 94 | 170 | 7 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.28e-05 | 104 | 170 | 7 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 3.09e-05 | 109 | 170 | 7 | GO:1902493 | |
| GeneOntologyCellularComponent | axon | MYO1D RASGRF1 PCDHGB1 POTEF CYP19A1 TRPC5 ACTB ACTG1 GRIA2 GRIA3 GRIA4 POTEKP GRIN2A IQGAP1 ITPR2 SLC6A1 POTEE SCN2A TANC1 POTEI | 3.93e-05 | 891 | 170 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | actin filament | 1.95e-04 | 146 | 170 | 7 | GO:0005884 | |
| GeneOntologyCellularComponent | Z disc | 2.40e-04 | 151 | 170 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | distal axon | RASGRF1 PCDHGB1 CYP19A1 TRPC5 ACTB ACTG1 GRIA2 GRIA3 GRIA4 GRIN2A IQGAP1 TANC1 | 2.40e-04 | 435 | 170 | 12 | GO:0150034 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1F TRPC5 GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 KCNA10 SCN2A | 2.78e-04 | 378 | 170 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | axon terminus | 3.31e-04 | 210 | 170 | 8 | GO:0043679 | |
| GeneOntologyCellularComponent | myofibril | 4.10e-04 | 273 | 170 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | I band | 4.27e-04 | 166 | 170 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 4.85e-04 | 45 | 170 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 5.28e-04 | 46 | 170 | 4 | GO:0005790 | |
| GeneOntologyCellularComponent | supramolecular fiber | DNAH3 POTEF ACTB CAMSAP3 OBSCN ACTG1 POTEKP KATNAL1 NEB RYR1 RYR2 IQGAP1 POTEE KY FBN2 SIMC1 KCNN2 ASB2 POTEI DNAH8 KIFC1 | 6.08e-04 | 1179 | 170 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.33e-04 | 290 | 170 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | neuron projection terminus | 6.59e-04 | 233 | 170 | 8 | GO:0044306 | |
| GeneOntologyCellularComponent | supramolecular polymer | DNAH3 POTEF ACTB CAMSAP3 OBSCN ACTG1 POTEKP KATNAL1 NEB RYR1 RYR2 IQGAP1 POTEE KY FBN2 SIMC1 KCNN2 ASB2 POTEI DNAH8 KIFC1 | 6.63e-04 | 1187 | 170 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 7.26e-04 | 50 | 170 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | sarcomere | 1.01e-03 | 249 | 170 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | terminal bouton | 1.13e-03 | 96 | 170 | 5 | GO:0043195 | |
| GeneOntologyCellularComponent | blood microparticle | 1.17e-03 | 144 | 170 | 6 | GO:0072562 | |
| GeneOntologyCellularComponent | dense body | 1.34e-03 | 7 | 170 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | NLRP3 inflammasome complex | 1.78e-03 | 8 | 170 | 2 | GO:0072559 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 1.83e-03 | 30 | 170 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO1D POTEF ACTB ACTG1 POTEKP NEB IQGAP1 POTEE GYS2 ASB2 POTEI MYO15A | 2.71e-03 | 576 | 170 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 2.83e-03 | 10 | 170 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.97e-03 | 73 | 170 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | cation channel complex | 3.17e-03 | 235 | 170 | 7 | GO:0034703 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 5.85e-05 | 23 | 132 | 4 | MP:0004088 | |
| MousePheno | abnormal urine progesterone level | 8.85e-05 | 2 | 132 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 8.85e-05 | 2 | 132 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 8.85e-05 | 2 | 132 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 8.85e-05 | 2 | 132 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 8.85e-05 | 2 | 132 | 2 | MP:0011546 | |
| Domain | Actin_CS | 2.04e-07 | 16 | 165 | 5 | IPR004001 | |
| Domain | ACTINS_2 | 2.88e-07 | 17 | 165 | 5 | PS00432 | |
| Domain | Actin/actin-like_CS | 3.95e-07 | 18 | 165 | 5 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 5.33e-07 | 19 | 165 | 5 | PS01132 | |
| Domain | Actin | 7.15e-06 | 31 | 165 | 5 | IPR004000 | |
| Domain | Actin | 7.15e-06 | 31 | 165 | 5 | PF00022 | |
| Domain | ACTIN | 7.15e-06 | 31 | 165 | 5 | SM00268 | |
| Domain | ARM-type_fold | DOCK1 SMG1 VEPH1 NCBP1 HEATR1 TRRAP FMNL2 ITPR2 SCYL2 FOCAD LRBA AGBL1 XPO7 | 1.03e-05 | 339 | 165 | 13 | IPR016024 |
| Domain | RIH_assoc-dom | 1.33e-05 | 6 | 165 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.33e-05 | 6 | 165 | 3 | PF08709 | |
| Domain | RIH_assoc | 1.33e-05 | 6 | 165 | 3 | PF08454 | |
| Domain | RIH_dom | 1.33e-05 | 6 | 165 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.33e-05 | 6 | 165 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.33e-05 | 6 | 165 | 3 | IPR015925 | |
| Domain | - | 1.33e-05 | 6 | 165 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.33e-05 | 6 | 165 | 3 | PF01365 | |
| Domain | Lig_chan-Glu_bd | 1.63e-05 | 18 | 165 | 4 | PF10613 | |
| Domain | Glu/Gly-bd | 1.63e-05 | 18 | 165 | 4 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.63e-05 | 18 | 165 | 4 | SM00918 | |
| Domain | Iontro_rcpt | 1.63e-05 | 18 | 165 | 4 | IPR001320 | |
| Domain | Iono_rcpt_met | 1.63e-05 | 18 | 165 | 4 | IPR001508 | |
| Domain | Lig_chan | 1.63e-05 | 18 | 165 | 4 | PF00060 | |
| Domain | PBPe | 1.63e-05 | 18 | 165 | 4 | SM00079 | |
| Domain | AAA | 4.26e-05 | 144 | 165 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 4.26e-05 | 144 | 165 | 8 | IPR003593 | |
| Domain | P-loop_NTPase | DNAH3 DDX49 MYO1D ABCA12 ATL3 RNF213 DHX33 KATNAL1 DDX3X IQGAP1 HELB ABCB10 RASD1 HFM1 ABCC12 DDX53 MYO15A DNAH8 KIFC1 RAD17 | 6.10e-05 | 848 | 165 | 20 | IPR027417 |
| Domain | Ion_trans_dom | 6.89e-05 | 114 | 165 | 7 | IPR005821 | |
| Domain | Ion_trans | 6.89e-05 | 114 | 165 | 7 | PF00520 | |
| Domain | DUOX1 | 7.76e-05 | 2 | 165 | 2 | IPR029595 | |
| Domain | Cyt_P450_mitochondrial | 7.76e-05 | 2 | 165 | 2 | IPR002399 | |
| Domain | S100A7 | 7.76e-05 | 2 | 165 | 2 | IPR028477 | |
| Domain | MIR | 7.76e-05 | 10 | 165 | 3 | PF02815 | |
| Domain | MIR_motif | 7.76e-05 | 10 | 165 | 3 | IPR016093 | |
| Domain | MIR | 7.76e-05 | 10 | 165 | 3 | PS50919 | |
| Domain | MIR | 7.76e-05 | 10 | 165 | 3 | SM00472 | |
| Domain | IQ | 8.15e-05 | 81 | 165 | 6 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.46e-04 | 90 | 165 | 6 | IPR000048 | |
| Domain | IQ | 1.75e-04 | 93 | 165 | 6 | PS50096 | |
| Domain | Ryanodine_rcpt | 2.31e-04 | 3 | 165 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 2.31e-04 | 3 | 165 | 2 | IPR009460 | |
| Domain | RyR | 2.31e-04 | 3 | 165 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 2.31e-04 | 3 | 165 | 2 | PF06459 | |
| Domain | Ryan_recept | 2.31e-04 | 3 | 165 | 2 | IPR013333 | |
| Domain | ANF_lig-bd_rcpt | 3.09e-04 | 37 | 165 | 4 | IPR001828 | |
| Domain | ANF_receptor | 3.09e-04 | 37 | 165 | 4 | PF01094 | |
| Domain | - | DNAH3 DDX49 ABCA12 ATL3 RNF213 DHX33 KATNAL1 DDX3X HELB ABCB10 RASD1 HFM1 ABCC12 DDX53 MYO15A DNAH8 RAD17 | 3.34e-04 | 746 | 165 | 17 | 3.40.50.300 |
| Domain | Peripla_BP_I | 3.80e-04 | 39 | 165 | 4 | IPR028082 | |
| Domain | IQ | 4.12e-04 | 71 | 165 | 5 | PF00612 | |
| Domain | DEAD/DEAH_box_helicase_dom | 4.69e-04 | 73 | 165 | 5 | IPR011545 | |
| Domain | DEAD | 4.69e-04 | 73 | 165 | 5 | PF00270 | |
| Domain | FAT | 1.14e-03 | 6 | 165 | 2 | PS51189 | |
| Domain | FATC | 1.14e-03 | 6 | 165 | 2 | PS51190 | |
| Domain | FATC_dom | 1.14e-03 | 6 | 165 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.14e-03 | 6 | 165 | 2 | IPR014009 | |
| Domain | FATC | 1.14e-03 | 6 | 165 | 2 | SM01343 | |
| Domain | NAD_binding_6 | 1.58e-03 | 7 | 165 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 1.58e-03 | 7 | 165 | 2 | PF08022 | |
| Domain | FAD-bd_8 | 1.58e-03 | 7 | 165 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 1.58e-03 | 7 | 165 | 2 | IPR013121 | |
| Domain | ACTINS_1 | 2.10e-03 | 8 | 165 | 2 | PS00406 | |
| Domain | DEAD_ATP_HELICASE | 2.54e-03 | 31 | 165 | 3 | PS00039 | |
| Domain | Helicase_C | 2.61e-03 | 107 | 165 | 5 | PF00271 | |
| Domain | HELICc | 2.61e-03 | 107 | 165 | 5 | SM00490 | |
| Domain | Helicase_C | 2.72e-03 | 108 | 165 | 5 | IPR001650 | |
| Domain | ARM-like | 2.81e-03 | 270 | 165 | 8 | IPR011989 | |
| Domain | HELICASE_CTER | 2.83e-03 | 109 | 165 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.83e-03 | 109 | 165 | 5 | PS51192 | |
| Domain | DEXDc | 2.83e-03 | 109 | 165 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.94e-03 | 110 | 165 | 5 | IPR014001 | |
| Domain | RNA-helicase_DEAD-box_CS | 3.04e-03 | 33 | 165 | 3 | IPR000629 | |
| Domain | Ank_2 | 3.05e-03 | 215 | 165 | 7 | PF12796 | |
| Domain | An_peroxidase | 3.33e-03 | 10 | 165 | 2 | PF03098 | |
| Domain | Haem_peroxidase_animal | 3.33e-03 | 10 | 165 | 2 | IPR019791 | |
| Domain | Haem_peroxidase | 3.33e-03 | 10 | 165 | 2 | IPR010255 | |
| Domain | PEROXIDASE_3 | 3.33e-03 | 10 | 165 | 2 | PS50292 | |
| Domain | - | 3.33e-03 | 10 | 165 | 2 | 1.10.640.10 | |
| Domain | Ank | 4.21e-03 | 228 | 165 | 7 | PF00023 | |
| Domain | Q_MOTIF | 4.22e-03 | 37 | 165 | 3 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 4.22e-03 | 37 | 165 | 3 | IPR014014 | |
| Domain | Ferric_reduct | 4.83e-03 | 12 | 165 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 4.83e-03 | 12 | 165 | 2 | IPR013130 | |
| Domain | GDS_CDC24_CS | 4.90e-03 | 39 | 165 | 3 | IPR001331 | |
| Domain | ABC_transporter_CS | 6.04e-03 | 42 | 165 | 3 | IPR017871 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.58e-03 | 14 | 165 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.58e-03 | 14 | 165 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.58e-03 | 14 | 165 | 2 | IPR013602 | |
| Domain | DHC_N2 | 6.58e-03 | 14 | 165 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 6.58e-03 | 14 | 165 | 2 | IPR011704 | |
| Domain | MT | 6.58e-03 | 14 | 165 | 2 | PF12777 | |
| Domain | AAA_8 | 6.58e-03 | 14 | 165 | 2 | PF12780 | |
| Domain | AAA_5 | 6.58e-03 | 14 | 165 | 2 | PF07728 | |
| Domain | - | 6.60e-03 | 248 | 165 | 7 | 1.25.40.20 | |
| Domain | ANK | 7.03e-03 | 251 | 165 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 7.33e-03 | 253 | 165 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 7.48e-03 | 254 | 165 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 7.48e-03 | 254 | 165 | 7 | PS50297 | |
| Domain | DHC_fam | 7.55e-03 | 15 | 165 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 7.55e-03 | 15 | 165 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 7.55e-03 | 15 | 165 | 2 | IPR004273 | |
| Domain | - | 8.58e-03 | 16 | 165 | 2 | 1.10.1070.11 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 1.73e-06 | 41 | 128 | 6 | M39655 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 1.80e-05 | 18 | 128 | 4 | M48098 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.44e-05 | 21 | 128 | 4 | M838 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 4.18e-05 | 22 | 128 | 4 | MM15104 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 6.70e-11 | 15 | 173 | 6 | 16824795 | |
| Pubmed | SMG1 MYO1D PCDHGB1 NELFCD POTEF ACTB CAMSAP3 ACTG1 DUOX2 GRIA2 GRIA3 GRIA4 NCBP1 TMEM43 HEATR1 NEB CHRNA1 RYR2 IQGAP1 POTEE SLC12A4 CLRN3 CEP83 ANKRD30A POTEI DNAH8 HDAC1 | 3.17e-09 | 1442 | 173 | 27 | 35575683 | |
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 18163426 | ||
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 29352045 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HGD SERPINA3 MYO1D UPK1A PSMB3 NEB CYRIB ITIH4 RYR1 DDX3X IQGAP1 MYOF SERPINA1 COPS8 CLRN3 GLG1 APPL1 MYO15A MVB12B TMEM63A | 1.90e-07 | 1016 | 173 | 20 | 19056867 |
| Pubmed | SMG1 NELFCD ACTB ACTG1 LAMB2 FMNL2 RYR2 DDX3X SCYL2 PPP1R26 FBN2 SLC12A4 ZNF341 ASB2 EPAS1 | 3.09e-07 | 591 | 173 | 15 | 15231748 | |
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 28608780 | ||
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 4.82e-07 | 4 | 173 | 3 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 4.82e-07 | 4 | 173 | 3 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 4.82e-07 | 4 | 173 | 3 | 17828255 | |
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 24652293 | ||
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 16179592 | ||
| Pubmed | Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. | 4.82e-07 | 4 | 173 | 3 | 10027300 | |
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 4.82e-07 | 4 | 173 | 3 | 12692557 | |
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 12125045 | ||
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 19120137 | ||
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 10688364 | ||
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 17409242 | ||
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 14561864 | ||
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 1319477 | ||
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 9648857 | ||
| Pubmed | 7.73e-07 | 15 | 173 | 4 | 9481670 | ||
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 1.20e-06 | 5 | 173 | 3 | 1717158 | |
| Pubmed | 1.20e-06 | 5 | 173 | 3 | 16129400 | ||
| Pubmed | 1.20e-06 | 5 | 173 | 3 | 9482932 | ||
| Pubmed | 1.20e-06 | 5 | 173 | 3 | 15797551 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.26e-06 | 38 | 173 | 5 | 30786075 | |
| Pubmed | 2.39e-06 | 6 | 173 | 3 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.39e-06 | 6 | 173 | 3 | 25966694 | |
| Pubmed | 2.39e-06 | 6 | 173 | 3 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.39e-06 | 6 | 173 | 3 | 16844763 | |
| Pubmed | 2.99e-06 | 45 | 173 | 5 | 25979088 | ||
| Pubmed | 4.17e-06 | 7 | 173 | 3 | 21368048 | ||
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 4.17e-06 | 7 | 173 | 3 | 33981040 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 4.17e-06 | 7 | 173 | 3 | 9016303 | |
| Pubmed | 4.17e-06 | 7 | 173 | 3 | 11860456 | ||
| Pubmed | 4.17e-06 | 7 | 173 | 3 | 27076426 | ||
| Pubmed | Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. | 4.17e-06 | 7 | 173 | 3 | 10407040 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 4.17e-06 | 7 | 173 | 3 | 9651535 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 5.81e-06 | 24 | 173 | 4 | 35746896 | |
| Pubmed | Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. | 6.65e-06 | 8 | 173 | 3 | 23217150 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 6.65e-06 | 8 | 173 | 3 | 19033399 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 6.99e-06 | 197 | 173 | 8 | 20811636 | |
| Pubmed | 8.89e-06 | 96 | 173 | 6 | 23580065 | ||
| Pubmed | 9.94e-06 | 9 | 173 | 3 | 24292102 | ||
| Pubmed | 9.94e-06 | 9 | 173 | 3 | 16364570 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 9.94e-06 | 9 | 173 | 3 | 9051806 | |
| Pubmed | AARS1 UPK1A ABCA12 POTEF ACTB CAMSAP3 ACTG1 POTEKP NEB CBR3 HELB POTEE | 1.11e-05 | 513 | 173 | 12 | 25798074 | |
| Pubmed | 1.12e-05 | 100 | 173 | 6 | 21800051 | ||
| Pubmed | 1.41e-05 | 10 | 173 | 3 | 16608528 | ||
| Pubmed | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. | 2.46e-05 | 2 | 173 | 2 | 28633507 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 23150505 | ||
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 2.46e-05 | 2 | 173 | 2 | 21778137 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 2.46e-05 | 2 | 173 | 2 | 21164264 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 2.46e-05 | 2 | 173 | 2 | 22366783 | |
| Pubmed | Intervertebral disc degeneration in adult mice with hereditary kyphoscoliosis. | 2.46e-05 | 2 | 173 | 2 | 6527158 | |
| Pubmed | Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders. | 2.46e-05 | 2 | 173 | 2 | 21984433 | |
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 2.46e-05 | 2 | 173 | 2 | 32588558 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 8645611 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 27625340 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 28813675 | ||
| Pubmed | Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain. | 2.46e-05 | 2 | 173 | 2 | 12231255 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 20634641 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 1303253 | ||
| Pubmed | Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells. | 2.46e-05 | 2 | 173 | 2 | 22523549 | |
| Pubmed | Elimination of redundant synaptic inputs in the absence of synaptic strengthening. | 2.46e-05 | 2 | 173 | 2 | 22090494 | |
| Pubmed | Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis. | 2.46e-05 | 2 | 173 | 2 | 23281318 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 17259277 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 31706280 | ||
| Pubmed | Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3. | 2.46e-05 | 2 | 173 | 2 | 12848940 | |
| Pubmed | Chromosome 14 linkage analysis and mutation study of 2 serpin genes in allergic asthmatic families. | 2.46e-05 | 2 | 173 | 2 | 11295654 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 19933774 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 2.46e-05 | 2 | 173 | 2 | 14722100 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 2.46e-05 | 2 | 173 | 2 | 19669888 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 2.46e-05 | 2 | 173 | 2 | 26009179 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 1741400 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 32540969 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 32899693 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 26047574 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 26324851 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 7669222 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 3221869 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 22933298 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 24349437 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 2783417 | ||
| Pubmed | Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity. | 2.46e-05 | 2 | 173 | 2 | 15972824 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 35984564 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 23613500 | ||
| Pubmed | Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. | 2.46e-05 | 2 | 173 | 2 | 2256920 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 20708777 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 2.46e-05 | 2 | 173 | 2 | 22217843 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 23362256 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 19144650 | ||
| Pubmed | Mitochondrial calcium overload is a key determinant in heart failure. | 2.46e-05 | 2 | 173 | 2 | 26217001 | |
| Pubmed | Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. | 2.46e-05 | 2 | 173 | 2 | 16396990 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 21215292 | ||
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 2.46e-05 | 2 | 173 | 2 | 18397978 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 1518866 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 11762710 | ||
| Interaction | GRIA4 interactions | 3.26e-08 | 41 | 161 | 7 | int:GRIA4 | |
| Interaction | ACTG2 interactions | 2.49e-06 | 49 | 161 | 6 | int:ACTG2 | |
| Interaction | GC interactions | 1.01e-05 | 62 | 161 | 6 | int:GC | |
| Interaction | ARPC2 interactions | 2.00e-05 | 187 | 161 | 9 | int:ARPC2 | |
| Interaction | UPK1A interactions | 2.81e-05 | 150 | 161 | 8 | int:UPK1A | |
| Interaction | ZNF674 interactions | 4.06e-05 | 9 | 161 | 3 | int:ZNF674 | |
| Cytoband | 2q21.1 | 7.05e-05 | 58 | 173 | 4 | 2q21.1 | |
| Cytoband | 16p12.3 | 2.89e-04 | 34 | 173 | 3 | 16p12.3 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 1.14e-06 | 4 | 120 | 3 | 1200 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.26e-06 | 13 | 120 | 4 | 685 | |
| GeneFamily | Cytochrome P450 family 11 | 1.30e-04 | 3 | 120 | 2 | 1007 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.30e-04 | 3 | 120 | 2 | 287 | |
| GeneFamily | Actins | 6.44e-04 | 6 | 120 | 2 | 929 | |
| GeneFamily | Glycosyl transferases group 1 domain containing | 1.90e-03 | 10 | 120 | 2 | 427 | |
| GeneFamily | DEAD-box helicases | 2.71e-03 | 42 | 120 | 3 | 499 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 184 | 173 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 184 | 173 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 184 | 173 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.51e-07 | 188 | 173 | 8 | a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-06 | 198 | 173 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-06 | 198 | 173 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 172 | 173 | 7 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | facs-Bladder|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-06 | 187 | 173 | 7 | dd5ca59417fd1b388fd975f0f3e1f3245d66ebc5 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.00e-05 | 191 | 173 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-05 | 191 | 173 | 7 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-05 | 191 | 173 | 7 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-05 | 196 | 173 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 196 | 173 | 7 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | COVID-19_Severe-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 1.18e-05 | 196 | 173 | 7 | 16359a56297f0558fc93fa52563cce0c53def167 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.22e-05 | 197 | 173 | 7 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | COVID-19_Severe-Neu_2|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 1.22e-05 | 197 | 173 | 7 | 945f19475905cdedf232315eea1076ca0b753b67 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-05 | 198 | 173 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-05 | 198 | 173 | 7 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.31e-05 | 199 | 173 | 7 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 173 | 7 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 173 | 7 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-05 | 145 | 173 | 6 | c0894c738815ff54790caddb4bccfa1503fd555b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 2.30e-05 | 146 | 173 | 6 | 1cb2e157222631e8915d89b255a843d16d7d99cc | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 2.49e-05 | 148 | 173 | 6 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Lrrtm2_(Cadm2_state)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.04e-05 | 46 | 173 | 4 | 61ce3bd406d297b62de88e5fd2262cf28b966645 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.22e-05 | 155 | 173 | 6 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.72e-05 | 159 | 173 | 6 | 6ec5489d55667e53bd9c021ada7de458bfef43a3 | |
| ToppCell | Paneth_cell|World / shred on cell type and cluster | 3.85e-05 | 160 | 173 | 6 | d787b7cdb8c3f677ac9c4934a5df9cc194df3987 | |
| ToppCell | C_07|World / shred on cell type and cluster | 3.85e-05 | 160 | 173 | 6 | b7c5a8a1c85da92e1945721b6887b32fad7b76b8 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 5.40e-05 | 170 | 173 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 5.58e-05 | 171 | 173 | 6 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_Interneurons|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.54e-05 | 176 | 173 | 6 | 62870115e31170c8b42eec57c709e0fe32388b37 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 6.54e-05 | 176 | 173 | 6 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-05 | 176 | 173 | 6 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | facs-Liver-Non-hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | f73ed860685a724591d0f543a9ac4e868aff92f5 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.96e-05 | 178 | 173 | 6 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 179 | 173 | 6 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 179 | 173 | 6 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.64e-05 | 181 | 173 | 6 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.87e-05 | 186 | 173 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.14e-05 | 187 | 173 | 6 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.41e-05 | 188 | 173 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.68e-05 | 189 | 173 | 6 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.97e-05 | 190 | 173 | 6 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.06e-04 | 192 | 173 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 193 | 173 | 6 | 268925bfe85fb94a93a4ff8fe078d692df888140 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 193 | 173 | 6 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 194 | 173 | 6 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 194 | 173 | 6 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 194 | 173 | 6 | 607b5d194ba56efa9b106f10f89368fc103712a0 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 194 | 173 | 6 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 194 | 173 | 6 | f5367072b259ae170cf0df3d4d871ab41be29d29 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 195 | 173 | 6 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 195 | 173 | 6 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | P15-Mesenchymal-myocytic_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.18e-04 | 196 | 173 | 6 | 41ae5b0d81ad09a6663335d899b4a1e4976c3b62 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 196 | 173 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-04 | 197 | 173 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-04 | 198 | 173 | 6 | 822df797fffbedf63ff8a8d99ea57511ce55f7cf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 198 | 173 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD8-Trm_gut_CD8|GI_large-bowel / Manually curated celltypes from each tissue | 1.25e-04 | 198 | 173 | 6 | 712f28a3cafcf209e51e9ebc2ce5013a4141bf6d | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.25e-04 | 198 | 173 | 6 | df546a9afc0e15398f33c1b511c7281771f9aea0 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.25e-04 | 198 | 173 | 6 | c4a004f211f72f28aacbb512c6e075cbd049be53 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-04 | 198 | 173 | 6 | 9b29232c8b4dcbd81f450f47c3f79bf26c8fb583 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-04 | 198 | 173 | 6 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 198 | 173 | 6 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.28e-04 | 199 | 173 | 6 | 0e696f13c9bd135fbb31368d6dca29897d6a1a25 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.28e-04 | 199 | 173 | 6 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.28e-04 | 199 | 173 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 199 | 173 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.28e-04 | 199 | 173 | 6 | 3feee9f53860b4b2e93ff2360beb2b2b74f51d24 | |
| ToppCell | control-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.28e-04 | 199 | 173 | 6 | 50e2da35edff1aadef939cfbd4549f73c1a07717 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 199 | 173 | 6 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.28e-04 | 199 | 173 | 6 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.28e-04 | 199 | 173 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.32e-04 | 200 | 173 | 6 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.32e-04 | 200 | 173 | 6 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.32e-04 | 200 | 173 | 6 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.32e-04 | 200 | 173 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.32e-04 | 200 | 173 | 6 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.32e-04 | 200 | 173 | 6 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.32e-04 | 200 | 173 | 6 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.32e-04 | 200 | 173 | 6 | 8b80811a0ec28d1d763c10b095d1969bccbe82d4 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.32e-04 | 200 | 173 | 6 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial-Proteoglycan-expressing_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.32e-04 | 200 | 173 | 6 | 52ec80f3922ae6ee3565d5993c2fc56bb3a3199a | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-04 | 200 | 173 | 6 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.32e-04 | 200 | 173 | 6 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Interneuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.32e-04 | 200 | 173 | 6 | c7e33057466915d4e2b34f2062b22d9cdffa69dc | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 1.32e-04 | 200 | 173 | 6 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.32e-04 | 200 | 173 | 6 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic-monocyte-CD14_monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.32e-04 | 200 | 173 | 6 | f65837b51bce94c08125b1a2e1a696a15267f64b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Rspo3_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 71 | 173 | 4 | 879551882097cfaa4eccf11cb07f3bae68c777c3 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Rspo3_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 71 | 173 | 4 | 8557be86709925cf19125e44c909133fd5adcb62 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.87e-04 | 73 | 173 | 4 | cc89c94a3768b02036757dea86989d9284b214b9 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.87e-04 | 73 | 173 | 4 | 6f28d52700bab981c8a3664ba4762f3572f7e788 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.87e-04 | 73 | 173 | 4 | ae80fcf3544c18fe0318a8311e96f2448f7cb03c | |
| Drug | isoxazole | 2.03e-07 | 56 | 171 | 7 | CID000009254 | |
| Drug | 7-chlorokynurenic acid | 1.05e-06 | 45 | 171 | 6 | CID000001884 | |
| Drug | 1NaPP1 | 1.45e-06 | 12 | 171 | 4 | CID000004877 | |
| Drug | 3-pyridazinol 1-oxide | 1.66e-06 | 4 | 171 | 3 | CID000574311 | |
| Drug | NSC3260 | 2.30e-06 | 195 | 171 | 10 | CID000220461 | |
| Drug | N-methyl-DL-aspartic acid | CACNA1F AMT RASGRF1 ICE2 TRPC5 GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 ITIH4 RYR1 RYR2 KY SERPINA1 JAG1 TANC1 LRBA | 2.32e-06 | 655 | 171 | 18 | CID000004376 |
| Drug | thiokynurenic acid | 3.93e-06 | 15 | 171 | 4 | CID003035667 | |
| Drug | AC1L1YEG | 4.12e-06 | 5 | 171 | 3 | CID000063114 | |
| Drug | Chicago acid | 4.12e-06 | 5 | 171 | 3 | CID000065740 | |
| Drug | CHEBI:570577 | 4.12e-06 | 5 | 171 | 3 | CID011334126 | |
| Drug | 1-BCP | 4.12e-06 | 5 | 171 | 3 | CID000001370 | |
| Drug | irampanel | 4.12e-06 | 5 | 171 | 3 | CID003038472 | |
| Drug | LY395153 | 4.12e-06 | 5 | 171 | 3 | CID000656707 | |
| Drug | beta-N-oxalylaminoalanine | 4.12e-06 | 5 | 171 | 3 | CID000107978 | |
| Drug | 5-h PCA | 4.12e-06 | 5 | 171 | 3 | CID000129091 | |
| Drug | LY233536 | 5.21e-06 | 16 | 171 | 4 | CID000126239 | |
| Drug | BAPTA | TRPC5 GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 SLC6A1 SETD2 MAPK14 LRBA | 6.58e-06 | 324 | 171 | 12 | CID000104751 |
| Drug | 7-Cl-Thio-Kyna | 6.77e-06 | 17 | 171 | 4 | CID003035668 | |
| Drug | PhTX-343 | 7.04e-06 | 36 | 171 | 5 | CID000159548 | |
| Drug | R,S)-AMPA | 7.04e-06 | 36 | 171 | 5 | CID000001221 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 8.09e-06 | 37 | 171 | 5 | CID000009643 | |
| Drug | YM928 | 8.19e-06 | 6 | 171 | 3 | CID006918393 | |
| Drug | 2cmo | 8.19e-06 | 6 | 171 | 3 | CID006914597 | |
| Drug | Tetrahydronaphthalenes | 8.19e-06 | 6 | 171 | 3 | ctd:D013764 | |
| Drug | MNQX | 8.66e-06 | 18 | 171 | 4 | CID000130818 | |
| Drug | GAMs | 9.26e-06 | 38 | 171 | 5 | CID000002935 | |
| Drug | octylmethoxycinnamate | 1.05e-05 | 139 | 171 | 8 | ctd:C118580 | |
| Drug | AC1L1GTT | 1.11e-05 | 233 | 171 | 10 | CID000003837 | |
| Drug | IDRA 21 | 1.35e-05 | 20 | 171 | 4 | CID000003688 | |
| Drug | 4,6-dichloroindole-2-carboxylic acid | 1.43e-05 | 7 | 171 | 3 | CID000127988 | |
| Drug | thio-ATPA | 1.43e-05 | 7 | 171 | 3 | CID005289517 | |
| Drug | AC1L1B62 | 1.66e-05 | 21 | 171 | 4 | CID000001299 | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 1.67e-05 | 194 | 171 | 9 | 7221_DN | |
| Drug | LY341495 | 1.72e-05 | 43 | 171 | 5 | CID006324636 | |
| Drug | saclofen | 1.93e-05 | 44 | 171 | 5 | CID000122150 | |
| Drug | NS 102 | 2.02e-05 | 22 | 171 | 4 | CID005282252 | |
| Drug | CX516 | 2.02e-05 | 22 | 171 | 4 | CID000148184 | |
| Drug | philanthotoxin | 2.16e-05 | 45 | 171 | 5 | CID000115201 | |
| Drug | homoibotenic acid | 2.27e-05 | 8 | 171 | 3 | CID000194385 | |
| Drug | 1-hydroxypyrazole | 2.27e-05 | 8 | 171 | 3 | CID003016733 | |
| Drug | 1-hydroxyimidazole | 2.27e-05 | 8 | 171 | 3 | CID003614351 | |
| Drug | 2,3-PDCA | 2.27e-05 | 8 | 171 | 3 | CID000127037 | |
| Drug | lamotrigine | 2.80e-05 | 116 | 171 | 7 | CID000003878 | |
| Drug | CGP 39653 | 2.90e-05 | 24 | 171 | 4 | CID006437837 | |
| Drug | Y-27632 | DOCK1 CYP19A1 PSMB3 ACTB ACTG1 MCF2 DUOX2 S1PR3 ITIH4 DUOX1 MAPK14 CD44 RASD1 | 3.28e-05 | 444 | 171 | 13 | CID000005711 |
| Drug | methylenecyclopropylglycine | 3.29e-05 | 49 | 171 | 5 | CID000441452 | |
| Drug | 1m5b | 3.38e-05 | 9 | 171 | 3 | CID000447081 | |
| Drug | Ly294486 | 3.38e-05 | 9 | 171 | 3 | CID005311255 | |
| Drug | isothiazol-3-one | 3.38e-05 | 9 | 171 | 3 | CID000096917 | |
| Drug | 2,2',3,4',5',6-hexachlorobiphenyl | 3.38e-05 | 9 | 171 | 3 | ctd:C120129 | |
| Drug | kynurenic acid | 3.87e-05 | 122 | 171 | 7 | CID000003845 | |
| Drug | 17-hydroxyprogesterone | 4.07e-05 | 123 | 171 | 7 | CID000006238 | |
| Drug | gabapentin | 4.30e-05 | 169 | 171 | 8 | CID000003446 | |
| Drug | AC1L1EKQ | 4.40e-05 | 52 | 171 | 5 | CID000002834 | |
| Drug | memantine | 4.70e-05 | 86 | 171 | 6 | CID000004054 | |
| Drug | perflubron | 4.81e-05 | 10 | 171 | 3 | ctd:C003072 | |
| Drug | Benzoates | 4.81e-05 | 10 | 171 | 3 | ctd:D001565 | |
| Drug | Indans | 4.81e-05 | 10 | 171 | 3 | ctd:D007189 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.50e-05 | 175 | 171 | 8 | 6891_DN | |
| Drug | enzacamene | 5.52e-05 | 129 | 171 | 7 | ctd:C038939 | |
| Drug | N-benzyl carbamate | 5.61e-05 | 2 | 171 | 2 | CID000230054 | |
| Drug | cyadox | 5.61e-05 | 2 | 171 | 2 | ctd:C020728 | |
| Drug | 18-hydroxydeoxycorticosterone | 5.61e-05 | 2 | 171 | 2 | ctd:C042509 | |
| Drug | AC1NUW3V | 6.30e-05 | 29 | 171 | 4 | CID005462126 | |
| Drug | aurintricarboxylic acid | 6.46e-05 | 91 | 171 | 6 | CID000002259 | |
| Drug | 2-amino-4-phosphonobutyric acid | 6.46e-05 | 91 | 171 | 6 | CID000002207 | |
| Drug | quinocarcin | 6.57e-05 | 11 | 171 | 3 | CID000158486 | |
| Drug | J-ST | 6.57e-05 | 11 | 171 | 3 | CID005288655 | |
| Drug | YM872 | 6.57e-05 | 11 | 171 | 3 | CID000148200 | |
| Drug | 0-ol | 6.57e-05 | 11 | 171 | 3 | CID000069892 | |
| Drug | sym 2206 | 6.57e-05 | 11 | 171 | 3 | CID005039877 | |
| Drug | LY293558 | 7.23e-05 | 30 | 171 | 4 | CID000127894 | |
| Drug | AC1L32TU | 7.23e-05 | 30 | 171 | 4 | CID000107831 | |
| Drug | 4-methylglutamic acid | 8.25e-05 | 31 | 171 | 4 | CID000005365 | |
| Drug | Atpa | 8.71e-05 | 12 | 171 | 3 | CID000002252 | |
| Drug | CB149 | 8.71e-05 | 12 | 171 | 3 | CID000038016 | |
| Drug | C-X6 | 8.71e-05 | 12 | 171 | 3 | CID005288002 | |
| Drug | caffeine | CACNA1F CYP11B1 CYP11B2 CYP19A1 GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 RYR1 RYR2 MAPK14 CCNB3 LRBA | 9.29e-05 | 562 | 171 | 14 | CID000002519 |
| Drug | M3/M4 | 9.37e-05 | 32 | 171 | 4 | CID000486507 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 9.37e-05 | 32 | 171 | 4 | CID000001222 | |
| Drug | pyrrolidine-2,4-dicarboxylate | 9.54e-05 | 61 | 171 | 5 | CID000003868 | |
| Drug | Prostaglandin E1; Up 200; 10uM; PC3; HT_HG-U133A | 9.79e-05 | 190 | 171 | 8 | 6571_UP | |
| Drug | K-Cl | SLC9A9 MYO1D CYP11B2 ACTB ACTG1 GRIN2A RYR1 RYR2 SETD2 SERPINA1 MAPK14 SLC12A4 JAG1 MYO15A | 1.02e-04 | 567 | 171 | 14 | CID000004873 |
| Drug | 6,7-dinitroquinoxaline | 1.06e-04 | 33 | 171 | 4 | CID002724608 | |
| Drug | pseudococaine | PSMB3 ACTB ACTG1 GRIA2 GRIA3 GRIA4 GRIN2A CHRNA1 ITIH4 SLC6A1 MAPK14 JAG1 CD44 RASD1 | 1.08e-04 | 570 | 171 | 14 | CID000002826 |
| Drug | GW8510; Up 200; 10uM; MCF7; HT_HG-U133A | 1.09e-04 | 193 | 171 | 8 | 7080_UP | |
| Drug | Naspm | 1.13e-04 | 13 | 171 | 3 | CID000129695 | |
| Drug | D-CPPene | 1.19e-04 | 34 | 171 | 4 | CID006435801 | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.30e-04 | 198 | 171 | 8 | 3691_UP | |
| Drug | kainite | 1.34e-04 | 35 | 171 | 4 | CID000164810 | |
| Drug | Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.35e-04 | 199 | 171 | 8 | 7473_DN | |
| Drug | peonidin | 1.43e-04 | 14 | 171 | 3 | CID000164544 | |
| Drug | quinoxaline-2,3-dione | 1.43e-04 | 14 | 171 | 3 | CID011469229 | |
| Drug | C6H12NO5P | 1.50e-04 | 36 | 171 | 4 | CID000104962 | |
| Drug | gamma-Glu-Gly | 1.67e-04 | 37 | 171 | 4 | CID000100099 | |
| Drug | gentamicin X2 | 1.67e-04 | 3 | 171 | 2 | CID000086483 | |
| Drug | cis-diammineplatinum(II | 1.67e-04 | 3 | 171 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.67e-04 | 3 | 171 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 1.67e-04 | 3 | 171 | 2 | CID000127713 | |
| Drug | aminodantrolene | 1.67e-04 | 3 | 171 | 2 | CID009570289 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 3.33e-06 | 6 | 164 | 3 | C1854678 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 9.25e-06 | 8 | 164 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 9.25e-06 | 8 | 164 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 9.25e-06 | 8 | 164 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 9.25e-06 | 8 | 164 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.97e-05 | 10 | 164 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.97e-05 | 10 | 164 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | Abnormality of refraction | SMG1 NRIP1 MYO1D RASGRF1 GRIA4 GRIN2A KATNAL1 DDX3X ADD3 ITPR2 SLC6A1 FBN2 SCN2A MVB12B | 2.57e-05 | 673 | 164 | 14 | HP_0000539 |
| Disease | Glucocorticoid-remediable aldosteronism | 3.07e-05 | 2 | 164 | 2 | C1260386 | |
| Disease | Baraitser-Winter syndrome | 3.07e-05 | 2 | 164 | 2 | cv:C1853623 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 3.07e-05 | 2 | 164 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 3.07e-05 | 2 | 164 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 3.07e-05 | 2 | 164 | 2 | C1853623 | |
| Disease | Congenital myopathy (disorder) | 3.57e-05 | 12 | 164 | 3 | C0270960 | |
| Disease | Manic | 7.59e-05 | 78 | 164 | 5 | C0338831 | |
| Disease | central nervous system disease (implicated_via_orthology) | 8.95e-05 | 16 | 164 | 3 | DOID:331 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 9.18e-05 | 3 | 164 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 9.18e-05 | 3 | 164 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 9.18e-05 | 3 | 164 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | phenylketonuria (implicated_via_orthology) | 1.83e-04 | 4 | 164 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 3.04e-04 | 5 | 164 | 2 | DOID:446 (is_implicated_in) | |
| Disease | Withdrawal Symptoms | 3.09e-04 | 58 | 164 | 4 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 3.09e-04 | 58 | 164 | 4 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 3.09e-04 | 58 | 164 | 4 | C0038587 | |
| Disease | Bipolar Disorder | RASGRF1 ACTB GRIA2 GRIA3 GRIN2A ITIH4 ADD3 SERPINA1 SCN2A DNAH8 | 3.55e-04 | 477 | 164 | 10 | C0005586 |
| Disease | Epilepsy | 3.66e-04 | 109 | 164 | 5 | C0014544 | |
| Disease | Schizophrenia | CACNA1F NRIP1 CNNM2 ACTB GRIA2 GRIA3 GRIA4 GRIN2A TRRAP SLC6A1 MAPK14 CELF2 JAG1 HDAC1 | 4.37e-04 | 883 | 164 | 14 | C0036341 |
| Disease | Conn Syndrome | 4.54e-04 | 6 | 164 | 2 | C1384514 | |
| Disease | Hyperaldosteronism | 4.54e-04 | 6 | 164 | 2 | C0020428 | |
| Disease | protocadherin alpha-7 measurement | 6.33e-04 | 7 | 164 | 2 | EFO_0801973 | |
| Disease | Uveoretinal Coloboma | 6.33e-04 | 7 | 164 | 2 | C4554007 | |
| Disease | skeletal age | 6.33e-04 | 7 | 164 | 2 | EFO_0020898 | |
| Disease | Manic Disorder | 6.69e-04 | 71 | 164 | 4 | C0024713 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 8.41e-04 | 8 | 164 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | nemaline myopathy (implicated_via_orthology) | 8.41e-04 | 8 | 164 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | kallistatin measurement | 8.41e-04 | 8 | 164 | 2 | EFO_0008196 | |
| Disease | osteoarthritis (is_marker_for) | 9.68e-04 | 35 | 164 | 3 | DOID:8398 (is_marker_for) | |
| Disease | Depression, Bipolar | 9.99e-04 | 79 | 164 | 4 | C0005587 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.05e-03 | 80 | 164 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.08e-03 | 9 | 164 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Congenital ocular coloboma (disorder) | 1.08e-03 | 9 | 164 | 2 | C0009363 | |
| Disease | alpha-1-antitrypsin measurement | 1.08e-03 | 9 | 164 | 2 | EFO_0008327 | |
| Disease | protein FAM163B measurement | 1.08e-03 | 9 | 164 | 2 | EFO_0802936 | |
| Disease | Epilepsy, Cryptogenic | 1.15e-03 | 82 | 164 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.15e-03 | 82 | 164 | 4 | C0751111 | |
| Disease | Aura | 1.15e-03 | 82 | 164 | 4 | C0236018 | |
| Disease | mean corpuscular hemoglobin concentration | CNNM2 WIPI1 POTEF ACTB NEB EZH1 CYRIB DMXL1 ITPR2 FOCAD TGIF1 HFM1 MYO15A ARMH4 XPO7 | 1.33e-03 | 1105 | 164 | 15 | EFO_0004528 |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.34e-03 | 10 | 164 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | Congenital neurologic anomalies | 1.34e-03 | 10 | 164 | 2 | C0497552 | |
| Disease | Cranioschisis | 1.34e-03 | 10 | 164 | 2 | C0265541 | |
| Disease | androstenedione measurement | 1.34e-03 | 10 | 164 | 2 | EFO_0007972 | |
| Disease | Moyamoya disease | 1.43e-03 | 40 | 164 | 3 | MONDO_0016820 | |
| Disease | Paranoia | 1.63e-03 | 11 | 164 | 2 | C1456784 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 1.63e-03 | 11 | 164 | 2 | EFO_0801461 | |
| Disease | peanut allergy measurement, parental genotype effect measurement | 1.63e-03 | 11 | 164 | 2 | EFO_0005939, EFO_0007017 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 1.63e-03 | 11 | 164 | 2 | EFO_0021862 | |
| Disease | Cognitive impairment | 1.63e-03 | 11 | 164 | 2 | HP_0100543 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.64e-03 | 152 | 164 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Mammary Neoplasms, Experimental | 1.78e-03 | 155 | 164 | 5 | C0024668 | |
| Disease | Neurodevelopmental Disorders | 1.83e-03 | 93 | 164 | 4 | C1535926 | |
| Disease | PR interval | 1.88e-03 | 495 | 164 | 9 | EFO_0004462 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.95e-03 | 12 | 164 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | uric acid measurement | 2.27e-03 | 610 | 164 | 10 | EFO_0004761 | |
| Disease | hypothyroidism (implicated_via_orthology) | 2.30e-03 | 13 | 164 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | breastfeeding duration | 2.67e-03 | 14 | 164 | 2 | EFO_0006864 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 2.67e-03 | 14 | 164 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | MMR-related febrile seizures | 3.07e-03 | 15 | 164 | 2 | EFO_0006519 | |
| Disease | Myopia | 3.07e-03 | 15 | 164 | 2 | C0027092 | |
| Disease | Autistic Disorder | 3.49e-03 | 261 | 164 | 6 | C0004352 | |
| Disease | 5-oxoproline measurement | 3.50e-03 | 16 | 164 | 2 | EFO_0010988 | |
| Disease | Idiopathic pulmonary arterial hypertension | 3.50e-03 | 16 | 164 | 2 | C3203102 | |
| Disease | Polyposis, Adenomatous Intestinal | 3.50e-03 | 16 | 164 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 3.50e-03 | 16 | 164 | 2 | C2713443 | |
| Disease | Drug habituation | 3.94e-03 | 115 | 164 | 4 | C0013170 | |
| Disease | Drug abuse | 3.94e-03 | 115 | 164 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.94e-03 | 115 | 164 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.94e-03 | 115 | 164 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.94e-03 | 115 | 164 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.94e-03 | 115 | 164 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.94e-03 | 115 | 164 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.94e-03 | 115 | 164 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.94e-03 | 115 | 164 | 4 | C0029231 | |
| Disease | migraine disorder | 3.94e-03 | 357 | 164 | 7 | MONDO_0005277 | |
| Disease | Moyamoya Disease | 3.95e-03 | 17 | 164 | 2 | C0026654 | |
| Disease | Adenomatous Polyposis Coli | 3.95e-03 | 17 | 164 | 2 | C0032580 | |
| Disease | Substance abuse problem | 4.07e-03 | 116 | 164 | 4 | C0740858 | |
| Disease | creatine kinase measurement | 4.36e-03 | 59 | 164 | 3 | EFO_0004534 | |
| Disease | open-angle glaucoma | 4.38e-03 | 191 | 164 | 5 | EFO_0004190 | |
| Disease | Lipoidosis | 4.93e-03 | 19 | 164 | 2 | C0023794 | |
| Disease | Cannabis use, age at onset | 4.93e-03 | 19 | 164 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | testosterone measurement | ATXN2L ZNF280D CYP11B1 CYP11B2 ICE2 CYP19A1 ACTG1 TMEM225B IQGAP1 RMI1 SERPINA1 FBN2 CLYBL MYO15A EPAS1 | 5.12e-03 | 1275 | 164 | 15 | EFO_0004908 |
| Disease | serum gamma-glutamyl transferase measurement | CYP11B1 ICE2 ACTG1 HSPA12B RYR2 RMI1 SETD2 SERPINA1 CELF2 GYS2 KCNN2 LRBA | 5.20e-03 | 914 | 164 | 12 | EFO_0004532 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | CNNM2 GRIA4 GRIN2A RYR2 RMI1 MAPK14 CELF2 CLYBL FEZF1 RAB3GAP2 SCN2A | 5.32e-03 | 801 | 164 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | smoking status measurement | CNNM2 GRIN2A TMEM225B RYR2 ADD3 FOCAD RMI1 CELF2 CLYBL FEZF1 RAB3GAP2 SCN2A DNAH8 ARMH4 | 5.45e-03 | 1160 | 164 | 14 | EFO_0006527 |
| Disease | temporal lobe epilepsy (is_marker_for) | 5.46e-03 | 20 | 164 | 2 | DOID:3328 (is_marker_for) | |
| Disease | BRCAX breast cancer | 5.46e-03 | 20 | 164 | 2 | EFO_0009443 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQPKSNSKMAELFME | 6 | Q6N043 | |
| PLMALSTTMAESFKE | 81 | Q6ZT62 | |
| SLFKPHLMAMNSIFD | 361 | Q99814 | |
| QMFMPFGNVISAKVF | 441 | O95319 | |
| MIFAGKAPSNTSTLM | 1 | Q9N2K0 | |
| MIIVPTDTQNIFFMS | 401 | P01011 | |
| SFSALMKALEMPQIT | 646 | O75815 | |
| SKSFISMEVPVMVVN | 616 | Q9UEY8 | |
| TFMHAKVLMFPATLT | 911 | Q6ULP2 | |
| TAFPATIMFAMKCLS | 476 | Q96Q27 | |
| TMETLTKFMQLHFPK | 2496 | Q86UK0 | |
| FLMIEQNTKSPLFMG | 396 | P01009 | |
| REKMTQIMFETFNTP | 116 | Q9BYX7 | |
| REKMTQIMFETFNTP | 116 | P60709 | |
| REKMTQIMFETFNTP | 116 | P63261 | |
| MMSAVPSATSLNKAF | 76 | Q86TY3 | |
| FVSRPTEKTIFMLFM | 201 | Q969M2 | |
| SPQAEFMFTQMVEKL | 231 | Q7Z2Y8 | |
| TVMVFFIMPAKTNNF | 361 | P54840 | |
| SKPFKVMMTAIISFF | 241 | Q49SQ1 | |
| SIPTKALELMDMQTF | 736 | Q9BXX3 | |
| SVGISMMFFVSPNLA | 301 | Q9NRK6 | |
| MMFFVSPNLATFVLS | 306 | Q9NRK6 | |
| FAPLQTFTDEEMMIK | 51 | P45954 | |
| MKFFMVLLPASLAST | 1 | Q8IVK1 | |
| MVVSTFTDMDTFPNN | 1 | Q9Y592 | |
| FTQIPAKTMSMSVDA | 1211 | Q9P1Y5 | |
| NSLKLSIFTPNVMMI | 586 | Q9Y485 | |
| DTMVFKPSDVMLVHF | 181 | Q8WWM7 | |
| TSSVVDFKMMAFPDV | 521 | Q96MI9 | |
| NSFFMEPMSFRKNPT | 561 | Q8WWL7 | |
| AFTFQGSMIDMPLLK | 311 | Q8N0X4 | |
| MELPKKAFITNFSMI | 71 | Q14624 | |
| KAFITNFSMIIDGMT | 76 | Q14624 | |
| FQMPQNKSTKFMDSV | 991 | P46940 | |
| QFPMDLNSKMSSVYL | 261 | Q09MP3 | |
| SFNPVAPTIMMKFLN | 286 | O75943 | |
| QMFRALFAMAKLPSE | 186 | Q9Y272 | |
| QFSPMMQAEFSVLVD | 1616 | Q14571 | |
| KAFAPIQEMMTFVQF | 266 | Q9NWY4 | |
| QAQMVTTDFQKIFPM | 31 | P49720 | |
| NDFFLVSTMKTPRTM | 381 | Q8NAB2 | |
| FIDTIPNIMFFSTMK | 336 | P02708 | |
| LGLKPQDMFVESMFS | 811 | Q9NRD9 | |
| FSKAEAFFPNMVNML | 576 | Q9UM07 | |
| GIMTLSPFDQMKTAS | 271 | Q9H2M9 | |
| NMVFTGLFTIEMVLK | 1226 | O60840 | |
| RHTMMFSATFPKEIQ | 376 | O00571 | |
| REKMTQIMFETFNTP | 816 | A5A3E0 | |
| AAPSMVAMFENFVSV | 141 | Q09161 | |
| NPADITVLFKMFTSM | 306 | Q8IXH7 | |
| SKVMEMFQPSAVVLQ | 246 | Q13547 | |
| MGFIAFSTMPELAQK | 191 | Q5VYY2 | |
| FADILFVTMPSQNML | 2821 | Q9UKN7 | |
| FNTRFVMKTLMTICP | 296 | Q9H2S1 | |
| SLTQMPKMNFANVFI | 261 | Q16539 | |
| TIESCAPTLFMFMLN | 371 | Q8NBH2 | |
| QLADAMMFPITQFKE | 106 | Q9UKG1 | |
| GLKPQDMFVESMFSL | 816 | Q9NRD8 | |
| SAKMLMFVNISPLEE | 631 | Q9BW19 | |
| DFSKPFMSLGISIMI | 511 | P42262 | |
| FSKPFMSLGISIMIK | 521 | P42263 | |
| IDFSKPFMSLGISIM | 511 | P48058 | |
| MPNSTTVMEFLLMRF | 1 | Q8NHC7 | |
| DKMVSAFYTILTPML | 271 | Q96R27 | |
| MSLASFATPKMIADF | 71 | Q96R72 | |
| MILASFATPKMIVDF | 71 | Q8NH42 | |
| MVTVASDKYLNSSPM | 46 | P0C623 | |
| MISCTDPSINFLMVF | 191 | Q8NGV7 | |
| EAEMMKSQVLFPFLL | 6 | Q9Y5G3 | |
| KSLNFSSATEPMMFQ | 2481 | Q96JB1 | |
| SFETAMMESTFPQQK | 656 | Q14D04 | |
| SAMQVSPLMFTDKAQ | 2491 | P50851 | |
| SPLMFTDKAQQDVIM | 2496 | P50851 | |
| LMASKSSATVFQNPM | 336 | P48552 | |
| THLIMTFKTFRPAAM | 146 | P55268 | |
| ILTFTSMPTLMQEFA | 446 | P49279 | |
| QSVFTNSSKEMMCFP | 56 | O60774 | |
| PLGMAFVTFQEKSMA | 346 | O94886 | |
| FSFASDPEAIHMMRK | 76 | Q96MM6 | |
| AMAATSFILMTTFPN | 331 | Q9UNZ2 | |
| ISAMDGVPFMISEKF | 251 | Q9H7P6 | |
| SPFRTEEEVMTQFMK | 176 | Q9Y6X9 | |
| MSFVDNCFSTTVPKM | 66 | Q96R84 | |
| KMISLSECMVQFFSL | 106 | Q8NGV6 | |
| EMSDISLSNSAMPKF | 1331 | A2PYH4 | |
| VSFRLHITEPKMMFA | 1061 | Q5VST9 | |
| ESFPELMTAAKFLLM | 131 | Q9HBE1 | |
| REKMTQIMFETFNTP | 816 | Q6S8J3 | |
| PMRKTFVSQASATMQ | 566 | Q8N573 | |
| VLSQTMFTDPFFMVE | 261 | Q16322 | |
| CFSTTITPKMLMSFV | 71 | Q8NGG6 | |
| FSDLAMQVMTSPSKN | 1131 | Q92896 | |
| MSKNTSVPVSAVFMD | 351 | Q659A1 | |
| FLENPLTAATKAMMS | 36 | Q9NZI5 | |
| ELSKMFTEFILNVPM | 816 | Q14185 | |
| FNSTLPTMAQMEKAL | 56 | P16070 | |
| AAPDTMSVSLFFMLF | 306 | P11511 | |
| IIQMNSKMSLIFEPA | 1821 | Q8TD57 | |
| FNNISKAPMSLVMFR | 2396 | Q8TD57 | |
| MQKIFSEPGSLSMAT | 306 | Q5TC63 | |
| FKSTVQLMFMPRSLS | 231 | P15538 | |
| LLAMKVPNVLTFDFM | 446 | Q9H6R0 | |
| SMSMPVLASFSKVDI | 311 | O43303 | |
| AMDEIFQKPFQTLMF | 196 | Q6DD88 | |
| KMTIMAFIGNFAESI | 781 | Q96PY5 | |
| DFMLKLPVVMLSSVS | 51 | P10911 | |
| FALTVKEMAQMLQSF | 101 | P10911 | |
| MPFDIKAEMTLKTNF | 101 | O75828 | |
| LQRPFQMSIDMGFKT | 296 | Q9BZJ6 | |
| MPVAVMAESAFSFKK | 1 | Q99627 | |
| MMLRKFSFPTVALHS | 266 | Q9Y6V7 | |
| FSFPTVALHSMMKQK | 271 | Q9Y6V7 | |
| VENMSPNDKVIMFVS | 461 | Q86TM3 | |
| MICKFLVQLSMDFSS | 481 | Q5D0E6 | |
| RMSLFYAEATPMLKT | 186 | Q9NUQ9 | |
| PDKVLHNIMSIFTFM | 1316 | Q9H583 | |
| FKSTVQLMFMPRSLS | 231 | P19099 | |
| SVDMDSPVNMKFNLS | 2796 | P35556 | |
| KLPFMTSAVMEVFGV | 201 | P48728 | |
| ESFLTSMGKFMKLIP | 131 | Q4AE62 | |
| SLLTMMKENFPNFLS | 31 | Q86SG5 | |
| SAMNPVIYTLASKEM | 291 | Q99500 | |
| SSNVEMILKFFDMFL | 4051 | P21817 | |
| MDLSFIKLTPSQEAM | 981 | Q92736 | |
| RNVMTALQFPKIMEF | 206 | Q8NG08 | |
| EFFTSLVKQEMVNMP | 776 | Q5VW36 | |
| MAFMFESSLSLAVTK | 396 | Q93099 | |
| ITFTFNKEMMSPGLT | 961 | P78504 | |
| SDPFAFMVTVKSMNT | 416 | P0C091 | |
| FMVTVKSMNTLVPVA | 421 | P0C091 | |
| LKSRTNMVLPFMIVF | 121 | Q9NYW0 | |
| DDPSKMVMVLAATNF | 346 | Q9BW62 | |
| NSFPSAFPIMIQESM | 41 | Q8N4H0 | |
| SAMAVESFMATAPFV | 171 | Q9BTV4 | |
| VFIFSAVQMTPLTMG | 511 | P30531 | |
| QPKQMMFTTTLLLVF | 456 | Q8IVB4 | |
| SAVFLAFVTTFIMMP | 81 | P0DP42 | |
| MNKTNIRFMEPDSLF | 381 | Q9H3W5 | |
| LMTISFNPSLSKAMV | 591 | Q9H9A7 | |
| KMAMFVVAGFNLSSS | 196 | Q8NGP8 | |
| NMMSTSKPLAFSIER | 21 | A0PJY2 | |
| AAMMISIVGFLSPFN | 51 | O75915 | |
| TPKMSAGQMLLVAFD | 2951 | Q96Q15 | |
| DPFFKMLNRSLSTFM | 121 | Q5JRX3 | |
| PTCSSNKIAEMMFGF | 681 | Q8NDZ2 | |
| MMFSTPTDNTKRNLT | 756 | Q6P3W7 | |
| TPFMGIMDKTARFQQ | 1721 | Q9C0D5 | |
| ASTFIISLFPTTMFM | 41 | P03915 | |
| MFLMNASPVVALQSK | 1 | Q5T8A7 | |
| REKMTQIMFETFNTP | 816 | P0CG38 | |
| VIFIPVQMFMAKLNS | 271 | Q96J65 | |
| IAMFNVMKFSIAILP | 381 | Q96J65 | |
| LMMNAFEENSKVTVP | 591 | Q13972 | |
| IASLDMVAPILSMFF | 571 | Q9UP95 | |
| MPTTKKTLMFLSSFF | 1 | Q8NCR9 | |
| EEKDFLMSQPLLMFS | 186 | Q2HXU8 | |
| MERKFMSLQPSISVS | 1 | Q9NS75 | |
| IFLTKFFMMMTFPAS | 376 | Q9H8M5 | |
| SVESVMGIKNFMPAL | 251 | Q15583 | |
| VVTFMIFMARDFATP | 2251 | Q63HN8 | |
| MLFSIRSFVSKMSPL | 41 | Q9Y5R8 | |
| LMSAMSAFTSLDQPM | 141 | Q9BYN7 | |
| KLFKMHSPQTSAMLF | 876 | P49588 | |
| GPMIEQLSKMFFTTK | 106 | Q9Y6G3 | |
| SLLTMMKENFPNFLS | 31 | P31151 | |
| FPNDMIFSAIASMFP | 231 | Q92800 | |
| IFTAEMFLKIIAMDP | 801 | Q99250 | |
| LSFMMPFDLMTNLTV | 71 | Q6ICG8 | |
| MFDLSMKDKTRSPFA | 151 | Q7L804 | |
| MVSNPSLITKQMLTF | 121 | O00322 | |
| IKQFMDIFSLPEMAL | 181 | Q9H857 | |
| NIEPSVMKISSNSFM | 811 | Q9BYW2 | |
| LVMQSMAFLQSSFPV | 151 | Q9H6L2 | |
| MLPLTAAFEAVAQMF | 691 | Q9UIA9 | |
| QVPTLMMDTQFSEFT | 126 | Q9UL62 | |
| KMFMAATNYLPTQVS | 281 | Q5MNZ9 | |
| FNLKSSPSSGELMFM | 856 | Q68DK2 | |
| AGVFTMMNPLTFKEI | 636 | Q9Y4A5 | |
| MMNPLTFKEIFQTTV | 641 | Q9Y4A5 | |
| QFMISKLLSSFMFTE | 111 | A8MPX8 | |
| KADFVLMDTVSMPEF | 11 | O94832 | |
| MKNFQMASITSPSLV | 1316 | Q9NZM1 | |
| ASMIMADKDPTSTFF | 131 | Q12879 | |
| QFKFSSLMDSIPMVL | 2696 | P20929 |